Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Chronic renal failure (CRF) is associated with uremic cardiomyopathy, featuring diastolic dysfunction, left ventricular hypertrophy, fibrosis, and oxidant stress.
• Elevated circulating concentrations of endogenous cardiotonic steroids (CTCs) are observed in CRF patients.
• The precise mechanisms linking CTCs to uremic cardiomyopathy remain incompletely understood.

Purpose of the Study:

• To review and highlight data supporting the hypothesis that CTCs are a key molecular factor in uremic cardiomyopathy.
• To elucidate the role of CTCs in the pathogenesis of diastolic dysfunction, left ventricular hypertrophy, fibrosis, and oxidant stress in chronic kidney disease.

Main Methods:

• This is a review article, synthesizing existing research and data.
• The review focuses on the molecular signaling pathways initiated by CTCs.
• Emphasis is placed on the interaction of CTCs with the Na/K-ATPase and subsequent reactive oxygen species (ROS) production.

Main Results:

• CTCs bind to the plasmalemmal Na/K-ATPase, initiating a signal cascade.
• This cascade generates reactive oxygen species (ROS), contributing to key features of uremic cardiomyopathy.
• The review posits CTCs as a potential mechanism for unexplained fibrosis and oxidant stress in CRF.

Conclusions:

• Endogenous cardiotonic steroids are implicated as a critical molecular component in the development of uremic cardiomyopathy.
• CTCs likely drive diastolic dysfunction, left ventricular hypertrophy, fibrosis, and systemic oxidant stress in chronic kidney disease.
• Targeting CTCs may offer a novel therapeutic strategy for managing uremic cardiomyopathy.